InvestorsHub Logo

eagle8

11/09/23 5:45 AM

#646160 RE: flipper44 #646159

Thanks for you response flipper.

Without expensive CI would of course be very nice, provided the results are adequate.
plx-3397, now owned by Merck, would be the only connection to a BP right?
Merck not happy with this I think.
Bullish
Bullish

marzan

11/09/23 5:48 AM

#646161 RE: flipper44 #646159

In other words, Kick those CIs out of the space and gain control of the whole oncology market …….Flipper the great!

eagle8

11/09/23 5:51 AM

#646164 RE: flipper44 #646159

Could this have something to do with the postponement of the patent application for DCvax + CI's ?

beachhyena

11/09/23 7:29 AM

#646180 RE: flipper44 #646159

Would explain the recent Merck purchase.

Doc logic

11/09/23 6:47 PM

#646377 RE: flipper44 #646159

flipper44,

I agree that patient specific combos are where this initially will be headed as a cost effective approach to treatment with the L/Poly ICLC use likely part of SOC and the other more patient specific. Poly ICLC is cheap compared to everything else. Best wishes.